Aakash Tulsani - Profile and Investment Details

Investor Profile

Aakash Tulsani is a Venture Capital, Private Equity Firm, Investor based in Singapore, Singapore with a diverse investment portfolio that includes companies such as PharmEasy, Carro, PAYFAZZ, Synack, BlackBuck (Zinka Logistics Solutions Pvt. Ltd.), Dailyhunt, Stord, Turing.com, Clari, INTURN, Appify, BYJU’S, Yalochat, Truera, Bright.md, Firstbase, DataRobot, Myia Labs, CareDox, Meesho, Certn, Reality AI, Bond, Phenom People, Plastiq, MoEngage Inc., Bounce, Bird, BlackbuckArmory, Centivo, Labelbox, Dragon Fund, Kandji, Journera, Zepto, Fishbrain, Auditoria.AI, FalconX, Mswipe Technologies Private Limited, Ula, Bolttech, Khatabook, Notable Labs, Ninja Van, Icertis, Evidation Health, Nektar.ai, Innovaccer, Kopi Kenangan, Cohesity, EmPath, CXA Group, Atomwise, VerSe Innovation, Capital Match, AImotive, Yubi, SilverCloud Health, Bizongo, . Over time, Aakash Tulsani has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Aakash Tulsani is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, E-commerce, Sports, Leisure, Wellness, Women Founded, Enterprise Software, Investment Management, HR Tech, Outpatient Care, Transportation, Apps, Credit Industry, Life Science, Portfolio Management, Banking, Education, Artificial Intelligence (AI), Retail, Information Services, Information Technology (IT), Marketplace, Analytics, Venture Fundraising, Mobile, Finance, Software, Biotechnology, iOS, Data Services, Electronic Health Records (EHR), Health and Hospital Services, Recreation, FinTech, Consumer Internet, Hardware, Social Media, Mergers and Acquisitions, Digital Health, Travel, Higher Education, SaaS, Big Data, Information Technology, B2B, Health Tech, Machine Learning, Personal Health, Pharmaceuticals, South Asian Founded, Acquisitions may find it worthwhile to explore potential connections with Aakash Tulsani, as their portfolio suggests a familiarity and interest in this area.

Understanding Aakash Tulsani’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.